{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:50:55Z","timestamp":1792029055697,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T00:00:00Z","timestamp":1492732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T00:00:00Z","timestamp":1492732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/cgt.2017.13","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T10:21:28Z","timestamp":1492770088000},"page":"259-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Correlations of TNF-\u03b1 gene promoter polymorphisms with the risk of thymoma-associated myasthenia gravis in a northern Chinese Han population"],"prefix":"10.1038","volume":"24","author":[{"given":"H-W","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-C","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z-L","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-H","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z-L","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"BFcgt201713_CR1","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","volume":"72","author":"A Alshekhlee","year":"2009","unstructured":"Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ . Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 2009; 72: 1548\u20131554.","journal-title":"Neurology"},{"key":"BFcgt201713_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/ane.12233","volume":"129","author":"JB Andersen","year":"2014","unstructured":"Andersen JB, Heldal AT, Engeland A, Gilhus NE . Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurol Scand Suppl 2014; 129: 26\u201331.","journal-title":"Acta Neurol Scand Suppl"},{"key":"BFcgt201713_CR3","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s12098-009-0201-3","volume":"76","author":"JB Ghosh","year":"2009","unstructured":"Ghosh JB, Roy M, Peters T . Thymoma associated with myasthenia gravis in infancy. Indian J Pediatr 2009; 76: 1057\u20131058.","journal-title":"Indian J Pediatr"},{"key":"BFcgt201713_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jneuroim.2008.07.012","volume":"201-202","author":"L Maggi","year":"2008","unstructured":"Maggi L, Andreetta F, Antozzi C, Baggi F, Bernasconi P, Cavalcante P et al. Thymoma-associated myasthenia gravis: outcome, clinical and pathological correlations in 197 patients on a 20-year experience. J Neuroimmunol 2008; 201-202: 237\u2013244.","journal-title":"J Neuroimmunol"},{"key":"BFcgt201713_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB . Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009; 8: 475\u2013490.","journal-title":"Lancet Neurol"},{"key":"BFcgt201713_CR6","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1074\/jbc.M005486200","volume":"276","author":"K Rutault","year":"2001","unstructured":"Rutault K, Hazzalin CA, Mahadevan LC . Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts. J Biol Chem 2001; 276: 6666\u20136674.","journal-title":"J Biol Chem"},{"key":"BFcgt201713_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10072-009-0023-0","volume":"30","author":"JS Lee","year":"2009","unstructured":"Lee JS, Joo IS, Seok JI . Widely varying TNF-alpha levels in patients with myasthenia gravis. Neurol Sci 2009; 30: 259\u2013262.","journal-title":"Neurol Sci"},{"key":"BFcgt201713_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1046\/j.1365-2265.2000.01011.x","volume":"52","author":"S Kamizono","year":"2000","unstructured":"Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A et al. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol 2000; 52: 759\u2013764.","journal-title":"Clin Endocrinol"},{"key":"BFcgt201713_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/1471-2407-9-238","volume":"9","author":"JJ Yang","year":"2009","unstructured":"Yang JJ, Ko KP, Cho LY, Shin A, Gwack J, Chang SH et al. The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study. BMC Cancer 2009; 9: 238.","journal-title":"BMC Cancer"},{"key":"BFcgt201713_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1749-6632.1998.tb10949.x","volume":"841","author":"P Hjelmstrom","year":"1998","unstructured":"Hjelmstrom P, Peacock CS, Giscombe R, Pirskanen R, Lefvert AK, Blackwell JM et al. Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region. Ann N Y Acad Sci 1998; 841: 368\u2013370.","journal-title":"Ann N Y Acad Sci"},{"key":"BFcgt201713_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nri916","volume":"2","author":"A Vincent","year":"2002","unstructured":"Vincent A . Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002; 2: 797\u2013804.","journal-title":"Nat Rev Immunol"},{"key":"BFcgt201713_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/ejcts\/ezw064","volume":"50","author":"B Orsini","year":"2016","unstructured":"Orsini B, Santelmo N, Pages PB, Baste JM, Dahan M, Bernard A et al. Comparative study for surgical management of thymectomy for non-thymomatous myasthenia gravis from the French national database EPITHOR. Eur J Cardiothorac Surg 2016; 50: 418\u2013422.","journal-title":"Eur J Cardiothorac Surg"},{"key":"BFcgt201713_CR13","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T . Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485\u20132492.","journal-title":"Cancer"},{"key":"BFcgt201713_CR14","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/S0003-4975(03)01139-1","volume":"76","author":"M Lopez-Cano","year":"2003","unstructured":"Lopez-Cano M, Ponseti-Bosch JM, Espin-Basany E, Sanchez-Garcia JL, Armengol-Carrasco M . Clinical and pathologic predictors of outcome in thymoma-associated myasthenia gravis. Ann Thorac Surg 2003; 76: 1643\u20131649; discussion 1649.","journal-title":"Ann Thorac Surg"},{"key":"BFcgt201713_CR15","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/S0003-4975(02)04083-3","volume":"74","author":"M de Perrot","year":"2002","unstructured":"de Perrot M, Liu J, Bril V, McRae K, Bezjak A, Keshavjee SH . Prognostic significance of thymomas in patients with myasthenia gravis. Ann Thorac Surg 2002; 74: 1658\u20131662.","journal-title":"Ann Thorac Surg"},{"key":"BFcgt201713_CR16","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1572-0241.2005.41737.x","volume":"100","author":"A Levine","year":"2005","unstructured":"Levine A, Shamir R, Wine E, Weiss B, Karban A, Shaoul RR et al. TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohn's disease. Am J Gastroenterol 2005; 100: 1598\u20131604.","journal-title":"Am J Gastroenterol"},{"key":"BFcgt201713_CR17","first-page":"406","volume":"22","author":"Y Liu","year":"2005","unstructured":"Liu Y, Guo XH, Du T, Li JH, Zhu XL, Gao JR et al. [Association of TNFA polymorphisms with the outcomes of HBV infection]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22: 406\u2013410.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"BFcgt201713_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5301\/JBM.2011.8580","volume":"26","author":"X Chen","year":"2011","unstructured":"Chen X, Zhang L, Chang Y, Shen T, Wang L, Zhuang H et al. Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a Han Chinese population. Int J Biol Markers 2011; 26: 181\u2013187.","journal-title":"Int J Biol Markers"},{"key":"BFcgt201713_CR19","doi-asserted-by":"publisher","first-page":"e19606","DOI":"10.1371\/journal.pone.0019606","volume":"6","author":"Q Xia","year":"2011","unstructured":"Xia Q, Zhou L, Liu D, Chen Z, Chen F . Relationship between TNF-&lt;alpha&gt; gene promoter polymorphisms and outcomes of hepatitis B virus infections: a meta-analysis. PLoS ONE 2011; 6: e19606.","journal-title":"PLoS ONE"},{"key":"BFcgt201713_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10875-012-9834-5","volume":"33","author":"Z Cheng","year":"2013","unstructured":"Cheng Z, Qiu S, Jiang L, Zhang A, Bao W, Liu P et al. MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1. J Clin Immunol 2013; 33: 567\u2013576.","journal-title":"J Clin Immunol"},{"key":"BFcgt201713_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/mus.21748","volume":"42","author":"G Galassi","year":"2010","unstructured":"Galassi G, Ariatti A, Codeluppi L, Meletti S . Comment on myasthenia gravis associated with TNF-alpha receptor blockers: A multifaceted issue. Muscle Nerve 2010; 42: 296\u2013298; author reply 298.","journal-title":"Muscle Nerve"},{"key":"BFcgt201713_CR22","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/annrheumdis-2011-201270","volume":"72","author":"GF Salinas","year":"2013","unstructured":"Salinas GF, De Rycke L, Barendregt B, Paramarta JE, Hreggvidstdottir H, Cantaert T et al. Anti-TNF treatment blocks the induction of T cell-dependent humoral responses. Ann Rheum Dis 2013; 72: 1037\u20131043.","journal-title":"Ann Rheum Dis"},{"key":"BFcgt201713_CR23","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1084\/jem.20051283","volume":"202","author":"A Craxton","year":"2005","unstructured":"Craxton A, Draves KE, Gruppi A, Clark EA . BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 2005; 202: 1363\u20131374.","journal-title":"J Exp Med"},{"key":"BFcgt201713_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.05.010","volume":"199","author":"JY Kim","year":"2008","unstructured":"Kim JY, Yang Y, Moon JS, Lee EY, So SH, Lee HS et al. Serum BAFF expression in patients with myasthenia gravis. J Neuroimmunol 2008; 199: 151\u2013154.","journal-title":"J Neuroimmunol"},{"key":"BFcgt201713_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","volume":"9","author":"F Mackay","year":"2009","unstructured":"Mackay F, Schneider P . Cracking the BAFF code. Nat Rev Immunol 2009; 9: 491\u2013502.","journal-title":"Nat Rev Immunol"},{"key":"BFcgt201713_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","volume":"52","author":"A Gradolatto","year":"2014","unstructured":"Gradolatto A, Nazzal D, Truffault F, Bismuth J, Fadel E, Foti M et al. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-alpha. J Autoimmun 2014; 52: 53\u201363.","journal-title":"J Autoimmun"},{"key":"BFcgt201713_CR27","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","volume":"118","author":"AG Fleischman","year":"2011","unstructured":"Fleischman AG, Aichberger KJ, Luty SB, Bumm TG, Petersen CL, Doratotaj S et al. TNFalpha facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms. Blood 2011; 118: 6392\u20136398.","journal-title":"Blood"},{"key":"BFcgt201713_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-2249.2000.01175.x","volume":"120","author":"V Ozenci","year":"2000","unstructured":"Ozenci V, Kouwenhoven M, Huang YM, Kivisakk P, Link H . Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Clin Exp Immunol 2000; 120: 147\u2013153.","journal-title":"Clin Exp Immunol"},{"key":"BFcgt201713_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1399-0039.1998.tb03002.x","volume":"51","author":"T Higuchi","year":"1998","unstructured":"Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H et al. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51: 605\u2013612.","journal-title":"Tissue Antigens"},{"key":"BFcgt201713_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.semnephrol.2007.02.004","volume":"27","author":"V Vielhauer","year":"2007","unstructured":"Vielhauer V, Mayadas TN . Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol 2007; 27: 286\u2013308.","journal-title":"Semin Nephrol"},{"key":"BFcgt201713_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/toxsci\/kfm209","volume":"100","author":"FF Tukov","year":"2007","unstructured":"Tukov FF, Luyendyk JP, Ganey PE, Roth RA . The role of tumor necrosis factor alpha in lipopolysaccharide\/ranitidine-induced inflammatory liver injury. Toxicol Sci 2007; 100: 267\u2013280.","journal-title":"Toxicol Sci"},{"key":"BFcgt201713_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cyto.2015.11.014","volume":"78","author":"E Sandoval-Pinto","year":"2016","unstructured":"Sandoval-Pinto E, Padilla-Gutierrez JR, Valdes-Alvarado E, Garcia-Gonzalez IJ, Valdez-Haro A, Munoz-Valle JF et al. Association of the -1031\u2009T&gt;C polymorphism and soluble TNF-alpha levels with Acute Coronary Syndrome. Cytokine 2016; 78: 37\u201343.","journal-title":"Cytokine"},{"key":"BFcgt201713_CR33","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1002\/art.30591","volume":"63","author":"E Giardina","year":"2011","unstructured":"Giardina E, Huffmeier U, Ravindran J, Behrens F, Lepre T, McHugh NJ et al. Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus. Arthritis Rheum 2011; 63: 3801\u20133806.","journal-title":"Arthritis Rheum"},{"key":"BFcgt201713_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2003.08.017","volume":"217","author":"NT Monsul","year":"2004","unstructured":"Monsul NT, Patwa HS, Knorr AM, Lesser RL, Goldstein JM . The effect of prednisone on the progression from ocular to generalized myasthenia gravis. J Neurol Sci 2004; 217: 131\u2013133.","journal-title":"J Neurol Sci"},{"key":"BFcgt201713_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","volume":"52","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Le Panse R . Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 2014; 52: 90\u2013100.","journal-title":"J Autoimmun"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201713.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201713","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cgt.2017.13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201713.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T13:09:56Z","timestamp":1647954596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFcgt201713"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2017.13","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,21]]},"assertion":[{"value":"8 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}